DaVita Inc
DVA138.480USD
-1.890-1.35%
Handelsschluss 08/01, 16:00（ET）Kurse um 15 Minuten verzögert
10.70BMarktkapitalisierung
12.45KGV TTM
mehr Informationen über DaVita Inc Unternehmen
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Unternehmensinformationen
BörsenkürzelDVA
Name des UnternehmensDaVita Inc
IPO-datumOct 31, 1995
Gegründet am1994
CEOMr. Javier J. Rodriguez
Anzahl der mitarbeiter76000
WertpapierartOrdinary Share
GeschäftsjahresendeOct 31
Addresse2000 16th St
StadtDENVER
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl80202-5117
Telefon13105362668
Websitehttps://www.davita.com/
BörsenkürzelDVA
IPO-datumOct 31, 1995
Gegründet am1994
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
837.84K
-4.28%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
25.58K
+1.38%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
20.58K
-84.60%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+31.62%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
14.28K
-14.14%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
13.20K
+2.71%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
12.66K
+2.83%
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Independent Director
6.45K
+5.70%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
837.84K
-4.28%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
101.00K
+8.83%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
66.98K
+12.40%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
25.58K
+1.38%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
20.58K
-84.60%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
15.96K
+31.62%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Patient service - Medicare and Medicare Advantage
1.61B
49.91%
Patient service - Commercial
1.01B
31.42%
Patient service - Other government
286.49M
8.89%
Patient service - Medicaid and Managed Medicaid
206.51M
6.41%
Other - Medicare and Medicare Advantage
98.95M
3.07%
Other
9.85M
0.31%
Keine Daten
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Patient service - Medicare and Medicare Advantage
1.61B
49.91%
Patient service - Commercial
1.01B
31.42%
Patient service - Other government
286.49M
8.89%
Patient service - Medicaid and Managed Medicaid
206.51M
6.41%
Other - Medicare and Medicare Advantage
98.95M
3.07%
Other
9.85M
0.31%
Aktionärsstatistik
Aktualisiert: Tue, Jul 29
Aktualisiert: Tue, Jul 29
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Berkshire Hathaway Inc.
44.76%
The Vanguard Group, Inc.
6.67%
BlackRock Institutional Trust Company, N.A.
3.86%
State Street Global Advisors (US)
2.91%
Weschler (R Ted)
2.89%
Other
38.91%
Aktionäre
Aktionäre
Anteil
Berkshire Hathaway Inc.
44.76%
The Vanguard Group, Inc.
6.67%
BlackRock Institutional Trust Company, N.A.
3.86%
State Street Global Advisors (US)
2.91%
Weschler (R Ted)
2.89%
Other
38.91%
Aktionärstypen
Aktionäre
Anteil
Holding Company
44.77%
Investment Advisor
27.26%
Investment Advisor/Hedge Fund
13.12%
Individual Investor
4.74%
Hedge Fund
3.31%
Pension Fund
1.70%
Research Firm
1.58%
Bank and Trust
1.05%
Sovereign Wealth Fund
0.08%
Other
2.38%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
1273
73.75M
97.68%
-6.66M
2025Q1
1300
76.19M
99.78%
-5.46M
2024Q4
1260
79.70M
99.28%
-3.76M
2024Q3
1214
80.97M
98.10%
-3.96M
2024Q2
1180
82.28M
96.62%
-4.32M
2024Q1
1166
84.15M
95.98%
-4.07M
2023Q4
1163
84.91M
95.56%
-3.04M
2023Q3
1159
85.40M
93.52%
-3.20M
2023Q2
1164
84.27M
92.30%
-4.64M
2023Q1
1168
84.01M
92.60%
-5.13M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Berkshire Hathaway Inc.
33.80M
44.76%
-1.35M
-3.83%
May 27, 2025
The Vanguard Group, Inc.
5.03M
6.67%
-160.20K
-3.08%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.91M
3.86%
-2.74K
-0.09%
Mar 31, 2025
State Street Global Advisors (US)
2.20M
2.91%
-147.00K
-6.27%
Mar 31, 2025
Weschler (R Ted)
2.18M
2.89%
--
--
Aug 06, 2024
Invesco Capital Management LLC
1.31M
1.73%
+73.07K
+5.91%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.19M
1.57%
+36.68K
+3.19%
Mar 31, 2025
LSV Asset Management
962.33K
1.27%
-66.10K
-6.43%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
877.32K
1.16%
-25.10K
-2.78%
Mar 31, 2025
Rodriguez (Javier J)
837.84K
1.11%
-37.42K
-4.28%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: 5 hours ago
Aktualisiert: 5 hours ago
Name
Anteil
Alpha Architect US Quantitative Value ETF
2.05%
Strategas Global Policy Opportunities ETF
1.98%
SPDR S&P Health Care Services ETF
1.97%
Aztlan Global Stock Selection DM SMID ETF
1.78%
Invesco S&P 500 Equal Weight Health Care ETF
1.71%
First Trust Health Care Alphadex Fund
1.65%
Pacer US Small Cap Cash Cows ETF
1.55%
Pacer US Cash Cows Growth ETF
1.43%
iShares U.S. Healthcare Providers ETF
0.93%
Global X Aging Population ETF
0.89%
Mehr Anzeigen
Alpha Architect US Quantitative Value ETF
Anteil2.05%
Strategas Global Policy Opportunities ETF
Anteil1.98%
SPDR S&P Health Care Services ETF
Anteil1.97%
Aztlan Global Stock Selection DM SMID ETF
Anteil1.78%
Invesco S&P 500 Equal Weight Health Care ETF
Anteil1.71%
First Trust Health Care Alphadex Fund
Anteil1.65%
Pacer US Small Cap Cash Cows ETF
Anteil1.55%
Pacer US Cash Cows Growth ETF
Anteil1.43%
iShares U.S. Healthcare Providers ETF
Anteil0.93%
Global X Aging Population ETF
Anteil0.89%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
